| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/18/2001 | CA2378989A1 Human lim domain proteins |
| 01/18/2001 | CA2378985A1 Atherosclerosis-associated genes |
| 01/18/2001 | CA2378982A1 Methods of inhibiting muscle atrophy |
| 01/18/2001 | CA2378921A1 Cell line comprising the promoter of cyclooxygenase-2 (cox-2) and a witness gene, and use thereof in the search of cox-2 transcriptional induction selective inhibitors |
| 01/18/2001 | CA2378846A1 Prostase vaccine |
| 01/18/2001 | CA2378796A1 Seripancrin |
| 01/18/2001 | CA2378786A1 G-protein coupled receptor and dna sequences thereof |
| 01/18/2001 | CA2378653A1 Methods and compositions for preventing the formation of aberrant rna during transcription of a plasmid sequence |
| 01/18/2001 | CA2378610A1 Human eag2 |
| 01/18/2001 | CA2378567A1 Novel myxoma genes for immune modulation |
| 01/18/2001 | CA2378501A1 Infection with chimaeric adenoviruses of cells negative for the adenovirus serotype 5 coxsacki adenovirus receptor (car) |
| 01/18/2001 | CA2378465A1 Manipulation of tissue or organ type using the notch pathway |
| 01/18/2001 | CA2378452A1 Antimicrobial peptides derived from molluscs |
| 01/18/2001 | CA2378407A1 Dna coding for beta-tubulin and use thereof |
| 01/18/2001 | CA2378240A1 Gamma-herpesvirus dna and methods of use |
| 01/18/2001 | CA2373534A1 Donor strand complemented pilin and adhesin broad-based vaccines |
| 01/17/2001 | EP1069182A1 Alleviation of symptoms associated with inflammatory disease states, using antibodies to CD18 |
| 01/17/2001 | EP1068799A2 Biological models capable of exhibiting secondary disease manifestations |
| 01/17/2001 | EP1068522A1 Antigen |
| 01/17/2001 | EP1068362A1 Hepatitis c virus ns5b compositions and methods of use thereof |
| 01/17/2001 | EP1068342A2 MODIFICATION OF FATTY ACID COMPOSITION IN PLANTS BY EXPRESSION OF AN $i(ASPERGILLUS NIDULANS) DELTA-9 COA DESATURASE |
| 01/17/2001 | EP1068341A1 Particle mediated transformation of soybean with glyphosate selection |
| 01/17/2001 | EP1068338A2 Enhanced prodrug activation |
| 01/17/2001 | EP1068336A2 Membranemetalloprotease nepii |
| 01/17/2001 | EP1068326A1 Novel sequence class of genes, corresponding proteins and the use of the same |
| 01/17/2001 | EP1068323A2 Recombinant major allergen of the pollen of artemisia vulgaris (mugwort) |
| 01/17/2001 | EP1068322A1 U4, a member of the hematopoietin receptor superfamily |
| 01/17/2001 | EP1068321A2 A interleukin-1 receptor antagonist and uses thereof |
| 01/17/2001 | EP1068318A2 Human nucleic acid sequences from prostate tissue |
| 01/17/2001 | EP1068317A2 Human nucleic acid sequences from prostate tumour tissue |
| 01/17/2001 | EP1068315A2 Therapeutic agent for ngf |
| 01/17/2001 | EP1068312A2 5' ests and encoded human proteins |
| 01/17/2001 | EP1068311A1 Methods and means for obtaining modified phenotypes |
| 01/17/2001 | EP1068308A1 Secreted proteins and polynucleotides encoding them |
| 01/17/2001 | EP1068307A1 Secreted proteins and polynucleotides encoding them |
| 01/17/2001 | EP1068300A1 Suppressive monocyte derived cells, process for their preparation and their uses in pharmaceutical compositions |
| 01/17/2001 | EP1068299A2 Use of stimulated peripheral blood mononuclear cells for the treatment of brain-related diseases, disorders and damage |
| 01/17/2001 | EP1068298A1 In vitro model for viral infection and immune response |
| 01/17/2001 | EP1068297A1 Use of monocytes derived cells, antigens and antibodies for optimal induction of immunotherapeutic efficiency |
| 01/17/2001 | EP1068296A1 Methods and compositions for eliciting an immune response to a telomerase antigen |
| 01/17/2001 | EP1068295A1 Cell differentiation/proliferation and maintenance factor and uses thereof |
| 01/17/2001 | EP1068292A1 Methods and apparatus for the conditioning of cartilage replacement tissue |
| 01/17/2001 | EP1068241A1 Antibody variants and fragments thereof |
| 01/17/2001 | EP1068238A1 An integrin heterodimer and a subunit thereof |
| 01/17/2001 | EP1068237A1 T cell receptor expression cassette |
| 01/17/2001 | EP1068236A1 Human oxidized ldl receptor |
| 01/17/2001 | EP1068231A2 Human nucleic acid sequences of normal ovary tissue |
| 01/17/2001 | EP1068220A1 nrdF |
| 01/17/2001 | EP1068217A1 Novel molecules of the card-related protein family and uses thereof |
| 01/17/2001 | EP1067968A1 Methods for evaluating a compound for its effect on skin |
| 01/17/2001 | EP1067952A1 Methods for treatment and prevention of infections |
| 01/17/2001 | EP1067944A1 New combined preparation for the treatment of neoplasic diseases or of infectious diseases |
| 01/17/2001 | EP1067917A2 Method of treating dopaminergic and gaba-nergic disorders |
| 01/17/2001 | EP1067909A1 Cationic lipid formulation delivering nucleic acid to peritoneal tumors |
| 01/17/2001 | EP1067893A2 Human galactosyl transferases |
| 01/17/2001 | CN1280627A Proteinase inhibitor fusion proteins |
| 01/17/2001 | CN1280624A Nucleic and molecules which encode proteins having fructosyl transterase activity and methods for producing long-chain inulin |
| 01/17/2001 | CN1280622A Modification of the tocopherol content of transgenic plants |
| 01/17/2001 | CN1280620A Antigen protein and nucleic acid coding for said protein |
| 01/17/2001 | CN1280619A (Chlamydia trachomatic) genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 01/17/2001 | CN1280618A Protein involved in abscisic acid signalling |
| 01/17/2001 | CN1280617A TSA 305 gene |
| 01/17/2001 | CN1280616A Method and compositions for inducing tumor-specific cytotoxicity |
| 01/17/2001 | CN1280615A Expression of endogenous genes by non-homologons recombination of a vactor construct with cellular DNA |
| 01/17/2001 | CN1280612A Differentiation of adipose stromal cells into osteobalsts and uses thereof |
| 01/17/2001 | CN1280611A Method and compositions for binding hematopoietic stem cells |
| 01/17/2001 | CN1280586A Erythropoietin with high specific activity |
| 01/17/2001 | CN1280501A Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 01/17/2001 | CN1280457A Nepovirus resistance in grapevine |
| 01/17/2001 | CN1280194A Culture fluid for T-lymphocytes |
| 01/17/2001 | CN1280191A Method for producing nucleic acid inhibiting albumen by inducing and cultivating trichoid root of chinese trichosanthes |
| 01/17/2001 | CN1280187A Method of extracorporeal cloning hemopoietic stem cell |
| 01/16/2001 | US6175061 Production of polyhydroxyalkanoate in plants |
| 01/16/2001 | US6175060 Transgenic plant having a cell transformed by a vector including dna which activates transcription of a structural gene under conditions of phosphate-starvation; recombinant production of proteins; disease resistance |
| 01/16/2001 | US6174995 Amino acid sequences of chemokine beta-4 and monocyte chemotactic protein-4; anticarcinogenic/antitumor agents; antifibrotic/antiarthritic/antiinflammatory agents; treatment of chronic infections, autoimmune disorders, psoriasis |
| 01/16/2001 | US6174994 7TM receptor (H2CAA71) |
| 01/16/2001 | US6174869 Method for enhancing neurone survival and agents useful for same |
| 01/16/2001 | US6174860 Nucleic acid isolated from a nematode symbiotic bacterium |
| 01/16/2001 | US6174733 Detection of pathogens using a column device with a sample containing a control |
| 01/16/2001 | US6174726 Method for the immortalization of cells using conditionally transformed helper cells |
| 01/16/2001 | US6174723 Cocaine derivative, protein conjugate thereof, monoclonal antibody producing cell line, method for preparing the cell line and monoclonal antibody |
| 01/16/2001 | US6174716 Expression system which produces a polypeptide of defined amino acid sequence in a compatible host cell; from adaptor protein which regulates phosphatidylinositol 3-kinase activity; antiinflammatory/antiarthritic agents; diagnosis |
| 01/16/2001 | US6174701 Neuronal factor |
| 01/16/2001 | US6174692 Detecting preferential antigen in sample; incubating monoclonal antibody with sample containing preferential antigen and detecting biinding |
| 01/16/2001 | US6174691 Deactivating a preferential tumor glycoprotein or a cell expressing preferential glycoprotein; exposing preferential glycoprotein or cell expressing the preferential glycoprotein to a toxic substance |
| 01/16/2001 | US6174685 Human herpesvirus type 6 protein p100, the corresponding DNA sequences, their preparation and use |
| 01/16/2001 | US6174676 Cytokine-stress- and oncoprotein-activated human protein kinase kinases |
| 01/16/2001 | US6174674 Detecting nucleotide sequence adjustment; hybridizing centromeric probe to human sample, hybridizing second teleomeric probe to human sample, detecting centromeric and telomeric hybridization positioning |
| 01/16/2001 | US6174666 Reducing adjustments in ribonucleic acid sequences; providing gene coding transcription products, detect regulatory sequences, insert point mutations, transfect mutated gene into cells, culture cells and monitoring gene expression |
| 01/16/2001 | US6174527 Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism |
| 01/16/2001 | US6174526 Blood-borne mesenchymal cells |
| 01/16/2001 | CA2313899A1 Novel selective imune down regulation (sidr) mediated transplantation processes, processes for preventing or treating diseases in a subject, and compositions of matter comprising trained or programmed cells, tissues or organs useful for sidr establishment |
| 01/16/2001 | CA2204355C Peripheral nervous system specific sodium channels, dna encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 01/16/2001 | CA2076979C Substantially pure transforming growth factor-.beta.-1-binding protein and nucleotide sequences expressing the binding protein |
| 01/16/2001 | CA2029861C Diagnosis and treatment of insulin dependent diabetes mellitus |
| 01/16/2001 | CA1341172C Synthetic insecticidal crystal protein gene |
| 01/16/2001 | CA1341170C Calcium channel compositions and methods |
| 01/16/2001 | CA1341167C Transformation and foreign gene expression in brassica species |
| 01/11/2001 | WO2001002609A2 Method of identifying toxic agents using differential gene expression |
| 01/11/2001 | WO2001002607A1 Adenovirus carrying gag gene hiv vaccine |